The AIM-HI Accelerator Fund (AIM-HI) aims to bring together a diverse community of cancer researchers, entrepreneurs, pharmaceutical industry leaders, biotech investors, patient advocates, and supporters to accelerate the development of cancer treatments and save patients' lives. Together with our strategic…
Sujuan Ba, Ph.D. has been awarded the Leadership Award for Global Advocate of Cancer Research by the Hong Kong Biotechnology Organization (HKBIO) at their BIOHK2023 Conference (September 13-16, Hong Kong Convention and Exhibition Centre). Dr. Ba is the President, CEO…
ROCKVILLE, MD – The AIM-HI Accelerator Fund, an emerging non-profit impact-investment organization committed to advancing early-stage, oncology companies, is pleased to announce an important update to its Board of Directors (BOD) leadership. Matt Tremblay, Ph.D., Chief Executive Officer of Blackbird…
ROCKVILLE, MD – The AIM-HI Accelerator Fund (AIM-HI) today announced the recipient of the 2023 AIM-HI Beacon Award for Women Leaders in Oncology as Monica M. Bertagnolli, M.D., Director of the National Cancer Institute (NCI). The Beacon Award for Women Leaders in Oncology…
Important Updates! It was our Big Day of the 2023 AIM-HI Women’s Venture Competition this Wednesday. We are thrilled to announce the 6 Semi-Finalists this year, selected from a pool of 71 applications submitted by women-led, early-stage oncology companies from…
Exciting news! The nomination process for the 2023 AIM-HI Beacon Award for Women Leaders in Oncology is now open through May 31! The AIM-HI Accelerator Fund (AIM-HI) wants to work with you to elevate, amplify, and celebrate women leaders in…
Have you heard? The application for the 2023 AIM-HI Women's Venture Competition is now open to women-led, early-stage oncology companies worldwide! Launched by the AIM-HI Accelerator Fund (AIM-HI) in 2020, this one-of-its-kind annual competition empowers women scientist-entrepreneurs in oncology by…
The AIM-HI Accelerator Fund (AIM-HI), together with our partner organizations, the National Foundation for Cancer Research and the Asian Fund for Cancer Research, successfully concluded the 2022 Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship on Saturday, October…
ROCKVILLE, MD – The AIM-HI Accelerator Fund (AIM-HI) today announced the recipient of its inaugural Beacon Award for Women Leaders in Oncology as Anna D. Barker, Ph.D., Chief Strategy Officer at the Lawrence J. Ellison Institute for Transformative Medicine. She…
The AIM-HI Accelerator Fund (AIM-HI) brings together a worldwide community of leaders in oncology to bridge the gap between laboratory discoveries and clinical trials, with the ultimate goal of developing innovative cancer therapies and technologies that can save patients’ lives.…
